Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2

Coronavirus disease 2019 (COVID-19) has affected millions of people worldwide. During the early stages of vaccination in Egypt, the ChAdOx1 nCoV-19 and BBIBP-CorV vaccines were the most distributed. The aim of this study was to compare the immune responses and short-term efficacies of these two vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelhafiz, Ahmed Samir, Ali, Asmaa, Kamel, Mahmoud M., Ahmed, Eman Hasan, Sayed, Douaa M., Bakry, Rania M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502803/
https://www.ncbi.nlm.nih.gov/pubmed/36146540
http://dx.doi.org/10.3390/vaccines10091462

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502803/
https://www.ncbi.nlm.nih.gov/pubmed/36146540
http://dx.doi.org/10.3390/vaccines10091462

Ejemplares similares